Literature DB >> 6850592

Glycoproteins as differentiation markers in human malignant melanoma and melanocytes.

T Tai, M Eisinger, S Ogata, K O Lloyd.   

Abstract

Human malignant melanoma cell lines have been divided into three broad groups on the basis of morphology, pigmentation, tyrosinase levels, the 2-dimensional electrophoretic patterns of their [3H]glucosamine-labeled glycoproteins and the presence or absence of an extracellular matrix of fibronectin. The most pigmented cell lines were characterized by the synthesis of a novel glycoprotein with a molecular weight of 75,000 and the absence of a fibronectin matrix. As cultured skin melanocytes also had these characteristics, this group of melanomas appears to be the most differentiated. Melanoma cell lines in the amelanotic group were characterized by the synthesis of high levels of HLA-DR antigen and by the production of an extracellular fibronectin matrix.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6850592

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Enhanced melanogenesis of murine melanoma cells cultured on or in collagen gel.

Authors:  T Kono; M Furukawa; T Tanii; N Mizuno; S Taniguchi; M Ishii; T Hamada
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma.

Authors:  Danny N Khalil; Michael A Postow; Nageatte Ibrahim; Dale L Ludwig; Jan Cosaert; Siva Rama Prasad Kambhampati; Shande Tang; Dmitri Grebennik; John Sae Wook Kauh; Heinz-Josef Lenz; Keith T Flaherty; F Stephen Hodi; Donald P Lawrence; Jedd D Wolchok
Journal:  Clin Cancer Res       Date:  2016-10-19       Impact factor: 12.531

3.  Substrate influences human epidermal melanocyte attachment and spreading in vitro.

Authors:  B A Gilchrest; L S Albert; R L Karassik; M Yaar
Journal:  In Vitro Cell Dev Biol       Date:  1985-02

4.  The TYRP1-mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains.

Authors:  Monika B Dolinska; Paul T Wingfield; Kenneth L Young; Yuri V Sergeev
Journal:  Pigment Cell Melanoma Res       Date:  2019-06-03       Impact factor: 4.693

5.  Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.

Authors:  V Feyles; W T Dixon; L K Sikora; R C McGarry; L M Jerry
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 6.  Proteoglycans and cell adhesion. Their putative role during tumorigenesis.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice.

Authors:  S Welt; M J Mattes; R Grando; T M Thomson; R W Leonard; P B Zanzonico; R E Bigler; S Yeh; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin.

Authors:  M Yamamoto; H Takahashi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Homozygous deletions within human chromosome band 9p21 in melanoma.

Authors:  J W Fountain; M Karayiorgou; M S Ernstoff; J M Kirkwood; D R Vlock; L Titus-Ernstoff; B Bouchard; S Vijayasaradhi; A N Houghton; J Lahti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Modulation of fibronectin production in normal human melanocytes and malignant melanoma cells by interferon-gamma and tumor necrosis factor-alpha.

Authors:  J Varani; R S Mitra; B J McClenic; S E Fligiel; D R Inman; V M Dixit; B J Nickoloff
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.